By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AnaptysBio, Inc. 

10421 Pacific Center Court
Suite 200
San Diego  California  92108  U.S.A.
Phone: 858-362-6295 Fax: 858-362-6296


Key Statistics

Ownership: Public

Web Site: AnaptysBio
Symbol: ANAB



Company News
AnaptysBio (ANAB) Announces Second Quarter 2017 Financial Results And Provides Pipeline Updates 8/11/2017 10:55:36 AM
AnaptysBio (ANAB) Announces First Quarter 2017 Financial Results And Provides Pipeline Update 5/12/2017 9:59:16 AM
AnaptysBio (ANAB) Release: SoCal Biotech Goes Public, Raises $75 Million 1/26/2017 6:42:09 AM
AnaptysBio Release: Biotech Announces The Appointment Of Dominic Piscitelli As Chief Financial Officer 1/11/2017 8:09:18 AM
AnaptysBio Announces Clearance Of U.S. IND And U.K. CTA For ANB020 12/13/2016 6:28:25 AM
AnaptysBio Reports ANB020 Top-Line Phase 1 Clinical Trial Results 10/3/2016 6:21:30 AM
AnaptysBio Announces Checkpoint Receptor Agonist Antibody Portfolio 9/26/2016 9:46:06 AM
AnaptysBio Initiates Multiple Ascending Dose Cohorts In ANB020 Phase 1 Clinical Trial 7/6/2016 6:11:26 AM
AnaptysBio Appoints Dr. Matthew Moyle As Chief Scientific Officer 4/18/2016 7:43:30 AM
AnaptysBio Announces First-In-Human Dosing Of Anti-IL-33 Antibody 3/10/2016 6:18:56 AM